Semaglutide — the active ingredient in Ozempic and Wegovy — has become one of the most widely used medications for weight loss and type 2 diabetes management. But as millions of women of reproductive age take it, an important question has emerged: what happens if you get pregnant on semaglutide?
The short answer is that semaglutide is not recommended during pregnancy, and current guidelines advise stopping it at least two months before attempting to conceive. But the picture is more nuanced — particularly because weight loss itself can restore fertility in women who had irregular cycles due to obesity or PCOS, making unintended pregnancies more likely while on the drug.
This article covers everything you need to know about semaglutide and pregnancy: the safety data, what to do if you discover you're pregnant while taking it, how to wean off properly, and what options exist for managing weight during pregnancy.
How Semaglutide Works — A Quick Refresher
Semaglutide is a GLP-1 receptor agonist. It mimics the hormone glucagon-like peptide-1, which is naturally released from your gut after eating. GLP-1 signals to the brain that you're full, slows gastric emptying, and stimulates insulin secretion. The result is reduced appetite, lower caloric intake, and — over time — significant weight loss.
GLP-1 receptors are found not just in the gut and pancreas, but throughout the body — including in the placenta and fetal tissues. This is one reason researchers and clinicians have concerns about fetal exposure to semaglutide during development.
Is Semaglutide Safe During Pregnancy?
At this time, semaglutide is classified as FDA Pregnancy Category not assigned (under the newer labeling system), but the prescribing information for both Ozempic and Wegovy explicitly states that it should not be used during pregnancy.
Animal studies are the basis for most of the concern. In rodent and rabbit studies, semaglutide exposure during pregnancy was associated with structural abnormalities, reduced fetal weight, and increased early pregnancy loss — particularly at doses higher than those used clinically. However, animal-to-human translation is imperfect, and the available human data is very limited.
The manufacturer (Novo Nordisk) operates a pregnancy exposure registry to collect real-world data on outcomes in women who become pregnant while taking semaglutide. As of 2026, data is still accumulating. We do not yet have robust human evidence confirming or ruling out fetal harm — which is precisely why avoidance is recommended as a precautionary principle.
Key Concerns for Fetal Development
- Teratogenicity: Animal data shows potential for structural birth defects, especially with first-trimester exposure
- Caloric restriction: Reduced appetite from semaglutide may limit nutrition available to the developing fetus
- Placental GLP-1 receptors: The drug could have direct effects on placental function
- Fetal growth: Animal studies showed reduced fetal and neonatal weight
The Fertility Paradox: Semaglutide Can Make Pregnancy More Likely
Here's a factor many women — and some providers — don't fully anticipate: semaglutide may restore fertility even while you're taking it.
Obesity and excess body fat are associated with hormonal disruption — elevated estrogen stored in fat tissue, insulin resistance, and anovulation (lack of ovulation). Women with PCOS in particular often experience irregular or absent periods due to these hormonal imbalances.
When weight loss occurs — whether from semaglutide or any other cause — ovulation can resume. Menstrual cycles that were previously irregular may normalize. Women who believed they were infertile may find themselves unexpectedly ovulating.
Additionally, oral contraceptives may become less effective with semaglutide use. Because the drug slows gastric emptying, it can alter how quickly pills are absorbed into the bloodstream. While this effect appears modest, it underscores the importance of discussing contraception with your provider.
What to Do If You Get Pregnant While on Semaglutide
First: don't panic. Accidental exposure does happen, and not every exposure results in harm. Here's a step-by-step approach:
- Stop semaglutide immediately. Do not take your next dose. The drug has a long half-life (~7 days), so it will clear your system over the following weeks — but stopping right away limits continued exposure.
- Contact your prescribing provider. Let them know about the pregnancy so they can document the exposure and advise on next steps.
- Schedule an OB/GYN appointment. A maternal-fetal medicine specialist may be appropriate depending on how far along you are and your specific health situation.
- Enroll in the pregnancy registry. Your provider can help enroll you in the Novo Nordisk pregnancy exposure registry, which collects data to improve safety understanding for future patients.
- Discuss diabetes management if applicable. If you were using semaglutide for type 2 diabetes, you'll need an alternative — insulin is considered the safest option during pregnancy.
Recommended Stopping Protocol Before Planned Pregnancy
If you are planning to become pregnant, current guidelines recommend stopping semaglutide at least 2 months (approximately 5 half-lives) before attempting conception. This allows the drug to fully clear from your system before a potential embryo would be forming.
| Step | Timing | Action |
|---|---|---|
| Discuss with provider | 3–4 months before trying | Review weight maintenance strategies, nutritional planning |
| Begin dose tapering | 2–3 months before trying | Gradually reduce dose (as advised) to minimize rebound appetite |
| Final dose | At least 2 months before trying | Stop medication entirely; drug clears in ~5 half-lives (~35 days) |
| Pre-conception period | 1–2 months before trying | Establish sustainable diet, prenatal vitamins, exercise routine |
| Begin trying | After 2-month washout | Semaglutide fully cleared; conception is safer |
Managing Weight During Pregnancy (Without Semaglutide)
Pregnancy is not the time for aggressive weight loss, but it is possible — and important — to manage weight gain appropriately. The Institute of Medicine provides guidelines based on pre-pregnancy BMI:
- Underweight (BMI < 18.5): Gain 28–40 lbs
- Normal weight (BMI 18.5–24.9): Gain 25–35 lbs
- Overweight (BMI 25–29.9): Gain 15–25 lbs
- Obese (BMI ≥ 30): Gain 11–20 lbs
For women with gestational diabetes or obesity-related complications, a registered dietitian and maternal-fetal medicine specialist can help design a safe nutrition plan. Safe activities like walking, swimming, and prenatal yoga support healthy weight management during pregnancy.
Returning to Semaglutide After Pregnancy and Breastfeeding
Semaglutide is also not recommended during breastfeeding. Animal studies show it is excreted in breast milk and could affect infant development. Once breastfeeding is complete, women may discuss resuming semaglutide with their provider for postpartum weight management if appropriate.
Many women experience significant postpartum weight retention — particularly those who gained above recommended amounts during pregnancy. Semaglutide can be an effective tool once the breastfeeding period has ended and a provider has cleared resumption.
Alternatives to Consider During Pregnancy Planning
If you're working toward pregnancy and want to continue making progress on weight, the following approaches are generally considered safe with appropriate provider oversight:
- Mediterranean-style diet: Anti-inflammatory, nutrient-dense, and fertility-supportive
- Moderate exercise: Helps maintain weight loss achieved with semaglutide
- Behavioral health support: Cognitive-behavioral approaches to eating patterns
- Metformin (for PCOS): Sometimes used under supervision for insulin resistance in early pregnancy — discuss risks/benefits with your OB
- Nutritional counseling: Personalized plans to sustain weight while optimizing fertility nutrients (folate, iron, omega-3s)
Always consult your healthcare provider before making any changes to your medication regimen, especially if you are pregnant or planning to become pregnant.
Frequently Asked Questions
Can semaglutide cause a miscarriage?
Animal studies showed increased early pregnancy loss at doses higher than typical clinical doses. There is no definitive human data confirming this risk, but the potential cannot be excluded. If you become pregnant while on semaglutide, stop immediately and contact your provider.
How long does semaglutide stay in your system?
Semaglutide has a half-life of approximately 7 days. It takes about 5 half-lives (roughly 35 days) to be substantially cleared from the body. Guidelines recommend stopping at least 2 months before trying to conceive to allow for full clearance.
Can semaglutide increase my chances of getting pregnant?
Indirectly, yes. Weight loss can restore ovulation in women who were anovulatory due to obesity or PCOS. This means women who believed they couldn't conceive may find fertility restored while on semaglutide — reinforcing the need for effective contraception while using it.
Is tirzepatide (Mounjaro/Zepbound) safer than semaglutide during pregnancy?
No. Tirzepatide carries similar precautions and is also contraindicated during pregnancy. The same stopping timeline (at least 2 months before trying) applies. Consult your provider about all GLP-1 medications when planning a family.
Will I gain back all the weight I lost when I stop semaglutide?
Some weight regain is common after stopping semaglutide without lifestyle changes in place. However, the degree of regain varies by individual and depends heavily on dietary habits and activity level. Working with a provider to establish sustainable lifestyle strategies before stopping can significantly reduce rebound weight gain.